US 6218382
Selective factor Xa inhibitors
expired A61KA61K38/00A61P
Quick answer
US patent 6218382 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 45
- CPC classes
- A61K, A61K38/00, A61P, A61P7/02